Recordati Industria Chimica e Farmaceutica SpA
Recordati Industria Chimica e Far.../ IT0003828271 /
REC/M
12.11.2024 17:35:15
|
Изменение
-0.93
|
Объем сделки |
Бид17:35:15 |
Предложение17:35:15 |
Рыночная капитализация |
Дивидендная доходность |
Коэффициент Цена/Доход |
51.28EUR
|
-1.77%
|
89,766 Оборот: 2.23 млн |
-Величина цены спроса: - |
-Величина цены предложения: - |
10.52 млрдEUR |
2.35% |
26.97 |
Описание деятельности
Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with a total staff of around 4,000, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases.
Правление & Наблюдательный совет
Исполнительный директор |
Robert Koremans |
Правление |
Andrea Recordati, Giampiero Mazza, Guido Guidi, Joanna Le Couilliard, Michaela Castelli, Piergiorgio Peluso, Cathrin Petty, Giorgio De Palma, Elisa Corghi, Luigi La Corte, Kim Stratton |
Наблюдательный совет |
Antonio Santi, Andrea Balelli, Ezio Simonelli, Livia Amidani Aliberti, Patrizia Oriundi Paleologo, Emiliano Nitti , Marco Antonio Viganò |
Данные компании
Имя: |
Recordati S.p.A. |
Адрес: |
via M. Civitali 1,I-20148 Milano |
Телефон: |
+39-02-48787-1 |
Факс: |
+39-02-40073-747 |
E-mail: |
-
|
Интернет: |
www.recordati.com/ |
Индустрия: |
Healthcare |
Сектор: |
Pharmaceutical Industry |
Подсектор: |
Pharmaceuticals |
Конец финансового года: |
31.12 |
Акции в свободном обращении: |
46.40% |
Дата IPO: |
01.01.1984 |
Связи с инвесторами
Имя: |
Marianne Tatschke |
IR телефон: |
- |
IR-факс: |
+39-02-48787-225 |
IR e-mail: |
inver@recordati.it
|
Календарь компании
CW 47 | 18.11.2024
Ex-Dividend
|
CW 47 | 19.11.2024
Record Date
|
CW 47 | 20.11.2024
Dividend Payment
|